Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial
Patients with rheumatoid arthritis (RA) have an increased risk of coronary artery disease (CAD) above the baseline. Baicalin possesses beneficial effects against both RA and CAD, but little is know on its clin...
Source: Lipids in Health and Disease - Category: Lipidology Authors: Yuanxing Hang, Xian Qin, Tianli Ren and Jianing Cao Tags: Research Source Type: research